Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized, double-blind, placebo- and active-controlled study of SAR407899A in mild to moderate erectile dysfunction
2009-009936-56Phase 2Completed
- Sponsor
- Sanofi
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of SAR407899A in erectile dysfunction (ED) (3 arms), sponsored by Sanofi. Primary endpoint: Duration of penile rigidity >60% at the base of the penis. Started May 2009; status: completed.
02
Drugs
SAR407899A
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on 2009-009936-56.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-009936-56.